InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-61.3%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the detailed record of transactions filed by Roberts Christopher D., Directeur Scientifique. Insider active across 1 company, notably Black Diamond Therapeutics, Inc.. Cumulatively, 2 reports have been recorded. History available since 3 May 2021. The latest transaction was disclosed on 3 May 2021 (Levée d'options). Regulator: SEC (Form 4). The full history is openly available.
Declarations2 total
◇
2,500 shares@ US$10.860.016% mcap50.0% of flowCommon StockSEC:0000899243-21-018358:0
◇
2,500 shares@ US$10.8650.0% of flowCommon StockSEC:0000899243-21-018358
2 of 2 declarations
About Roberts Christopher D.
Roberts Christopher D. is the Chief Scientific Officer of Black Diamond Therapeutics, Inc. In this role, he is responsible for research and development of new treatments, contributing to innovation in the biopharmaceutical sector.
